Laureano Simon

Laureano Simon, Angel investor in Spain is an active investor based in Spain. This profile covers what Laureano Simon backs, at which stage, and how founders can reach out in 2026.

Dr. Laureano Simon serves as Chief Executive Officer at Patia Europe. Dr. Simon served as Board Member at StemTek Therapeutics. Dr. Simon is a Co-Founder and serves as Chief Executive Officer at Oncomatryx. Founder of Oncomatryx and other biotech companies including Patia and Progenika, which he later sold to Grifols for €90m EnValue. He has received the Euro Awards Award for Entrepreneurs (2004), Ernst & Young Year's Most Innovative Entrepreneur (2010), and the Ruban d'honneur in the European Business Awards, HSBC Bank (2011). He holds a Ph.D. in Biochemistry and Molecular Biology from the Autonomous University of Madrid, an M.Sc. in Biotechnology from the University of Navarre, an M.Sc. from the University of Wisconsin-Madison, and a BSc in Pharmacy from the University of Santiago de Compostela. He is an investor and member of the Board of Directors since 2016. He has founded, invested in, and served as a director for over a dozen companies in the private biotech sector. He was the founder and CEO of Progenika Biopharma, which he later sold to Grifols. He has received the Eurowards Award for Entrepreneurs (2004), Ernst & Young Most Innovative Entrepreneur (2010), and the Ris a Co-Founderuban d'honneur in the European Business Awards, HSBC Bank (2011).